BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23710207)

  • 1. Association analysis of CUZD1 variants in European chronic pancreatitis patients.
    Just A; Thiel FG; Weiss FU
    Pancreatology; 2023 Dec; 23(8):1041-1042. PubMed ID: 37858432
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic Profiling of the Atlantic Salmon Gill by Single Nuclei Transcriptomics.
    West AC; Mizoro Y; Wood SH; Ince LM; Iversen M; Jørgensen EH; Nome T; Sandve SR; Martin SAM; Loudon ASI; Hazlerigg DG
    Front Immunol; 2021; 12():669889. PubMed ID: 34017342
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Cohen JD; Sundaram MV
    J Dev Biol; 2020 Oct; 8(4):. PubMed ID: 33036165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia.
    Lopens S; Krawczyk M; Papp M; Milkiewicz P; Schierack P; Liu Y; Wunsch E; Conrad K; Roggenbuck D
    Auto Immun Highlights; 2020 Mar; 11(1):6. PubMed ID: 32178720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
    Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
    J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient and Prolonged Response of Chicken Cecum Mucosa to Colonization with Different Gut Microbiota.
    Volf J; Polansky O; Varmuzova K; Gerzova L; Sekelova Z; Faldynova M; Babak V; Medvecky M; Smith AL; Kaspers B; Velge P; Rychlik I
    PLoS One; 2016; 11(9):e0163932. PubMed ID: 27685470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coherent somatic mutation in autoimmune disease.
    Ross KA
    PLoS One; 2014; 9(7):e101093. PubMed ID: 24988487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies.
    Bogdanos DP; Rigopoulou EI; Smyk DS; Roggenbuck D; Reinhold D; Forbes A; Laass MW; Conrad K
    Autoimmun Rev; 2011 Dec; 11(2):143-8. PubMed ID: 21983481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological studies in inflammatory bowel disease: how important are they?
    Papp M; Lakatos PL
    Curr Opin Gastroenterol; 2014 Jul; 30(4):359-64. PubMed ID: 24811052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases.
    Liaskos C; Rigopoulou EI; Orfanidou T; Bogdanos DP; Papandreou CN
    Clin Dev Immunol; 2013; 2013():968041. PubMed ID: 23710207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases.
    Farkona S; Soosaipillai A; Filippou P; Liaskos C; Bogdanos DP; Diamandis EP; Blasutig IM
    Clin Chem Lab Med; 2017 Aug; 55(10):1574-1581. PubMed ID: 28343172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease.
    Michaels MA; Jendrek ST; Korf T; Nitzsche T; Teegen B; Komorowski L; Derer S; Schröder T; Baer F; Lehnert H; Büning J; Fellerman K; Sina C
    Inflamm Bowel Dis; 2015 Dec; 21(12):2864-72. PubMed ID: 26273818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2.
    Komorowski L; Teegen B; Probst C; Aulinger-Stöcker K; Sina C; Fellermann K; Stöcker W
    J Crohns Colitis; 2013 Nov; 7(10):780-90. PubMed ID: 23140841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].
    Papp M; Sipeki N; Tornai T; Altorjay I; Norman GL; Shums Z; Roggenbuck D; Fechner K; Stöcker W; Antal-Szalmas P; Veres G; Lakatos PL
    J Crohns Colitis; 2015 Aug; 9(8):659-68. PubMed ID: 25968583
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.